Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
113.08
+0.42 (0.37%)
At close: Aug 18, 2026, 4:00 PM EDT
111.72
-1.36 (-1.20%)
After-hours: Aug 18, 2026, 5:15 PM EDT
Oruka Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $180 | Buy | Maintains | $180 | +59.18% | Aug 17, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $125 → $175 | Buy | Maintains | $125 → $175 | +54.76% | Aug 15, 2026 |
| Wedbush | Wedbush | Buy Initiates $165 | Buy | Initiates | $165 | +45.91% | Aug 12, 2026 |
| Jefferies | Jefferies | Buy Maintains $133 | Buy | Maintains | $133 | +17.62% | Aug 11, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $200 | Buy | Reiterates | $200 | +76.87% | Aug 11, 2026 |
| BTIG | BTIG | Buy Maintains $151 | Buy | Maintains | $151 | +33.53% | Aug 11, 2026 |
| Barclays | Barclays | Buy Maintains $160 | Buy | Maintains | $160 | +41.49% | Aug 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $120 | Buy | Reiterates | $120 | +6.12% | Aug 3, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.